Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens, in vitro biological activities, pharmacokinetics and antitumor activity

C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens, in vitro biological activities, pharmacokinetics and antitumor activity

US Patent 10098896 · Granted Oct 16, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for production of novel galeterone analogs and uses thereof2025
Methods of treating pancreatic cancer2023
13-cis-RAMBA retinamides that degrade MNKs for treating cancer2020
Methods of treating pancreatic cancer2020
Nonsteroidal and steroidal compounds with potent androgen receptor down-regulati2020
Androgen receptor down-regulating agents and uses thereof2018
Biomarkers for treatment of neoplastic disorders using androgen-targeted therapi2017
Nonsteroidal and steroidal compounds with potent androgen receptor down-regulati2017
Androgen receptor down-regulating agents and uses thereof2016
Biomarkers for treatment of neoplastic disorders using androgen-targeted therapi2016
Prodrugs of C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis,2016
Prodrugs of C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis,2016